|
WO2007020521A1
|
|
Pyridoyrazinones as pde-5 inhibitors
|
|
EP1912936A2
|
|
Stereoselective synthesis of 3,4-disubstituted cyclopentanones and related compounds
|
|
WO2007004032A1
|
|
Oxazolidiones containing cyclobutane as antibacterial agents
|
|
EP1902048A1
|
|
Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents
|
|
WO2007004049A1
|
|
Oxazolidinones containing azetidine as antibacterial agents
|
|
EP1899331A1
|
|
Homomorpholine oxazolidinones as antibacterial agents
|
|
CA2603830A1
|
|
Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
|
|
CA2608672A1
|
|
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
|
WO2006126083A1
|
|
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
|
AU2006231916A1
|
|
Formulations and process for production of Bordetella bronchiseptica p68 antigen and vaccines
|
|
CA2603943A1
|
|
An oxindole oxazolidinone as antibacterial agent
|
|
AU2006231919A1
|
|
7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
|
|
CA2602358A1
|
|
4-piperazinnylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
CA2602227A1
|
|
4-piperazinylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
CA2603041A1
|
|
4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
|
|
BRPI0609435A2
|
|
preparation of optically pure beta amino acids having affinity for alpha-2-delta protein
|
|
RU2356579C1
|
|
Composition of ctla-4 antibodies
|
|
JP2006249082A
|
|
Anti-m-csf antibody composition having endotoxin in reduced level
|
|
JP2006249084A
|
|
ANTI-MadCAM ANTIBODY COMPOSITION
|
|
CA2595675A1
|
|
Form iv crystalline celecoxib
|
